A woman sat nervously in front of me, eyes wide, voice low. “I saw this video on TikTok,” she said. “Now I’m not sure I want to try it.” “It” was semaglutide—one of the most transformative medications we’…
Category: Obesity
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
A new drug is helping families who’ve spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress — and a broader understanding of obesity — is now under threat as the government dismantles the pipeline for promising new research.
Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.
The truth about GLP-1 medications for weight loss: What every patient should know
For years, weight loss has been sold as a simple math problem: eat less, move more, and the pounds will melt away. But if that were true, we wouldn’t have an obesity epidemic affecting over 40 percent of adults in the U.S. Now, a new class of med…
How has the Burden of Chronic Diseases in the U.S. and Peer Nations Changed Over Time?
Chronic, non-communicable diseases are the leading cause of death worldwide and make up 8 of the 10 top causes of death in the U.S. Across several chronic diseases, the U.S. has a higher burden of illness than peer nations. The reasons why are complex …
Junk Food Turns Public Villain as Power Shifts in Washington
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entrée will result in any meaningful change in government oversight of “Big Food” — or in American health.
Journalists Dig Into Vaccine Debate and America’s Obesity Rates
KFF Health News staff made the rounds on national and local media in recent weeks to discuss topical stories. Here’s a collection of their appearances.
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs
More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, accordin…
A gastroenterology approach to obesity [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! In this episode, we dive into the complexities of obesity with gastroenterologist Pooja Singhal. Together, we explore the media’s portrayal of new obesity medication…
